Whole Genome Sequencing of HER2-Positive Metastatic Extramammary Paget’s Disease
Single patient case of HER2-Positive Metastatic Extramammary Paget’s Disease
- 03/04/2024
- 2 samples
- DAC: EGAC00001001550
- Technology: Illumina NovaSeq 6000
DUO:0000043 version: 2021-02-23
clinical care use
This data use modifier indicates that use is allowed for clinical use and care.
DUO:0000045 version: 2021-02-23
not for profit organisation use only
This data use modifier indicates that use of the data is limited to not-for-profit organizations.
DUO:0000046 version: 2021-02-23
non-commercial use only
This data use modifier indicates that use of the data is limited to not-for-profit use.
Unpublished
Unpublished
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS50000000243 | Whole Genome Sequencing |
